Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2011

Open Access 01-12-2011 | Research

Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study

Authors: Jing Yang, Shengyi Wang, Guofan Zhao, Baocun Sun

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2011

Login to get access

Abstract

Background

The expression of chemokine receptors CCR7 has been studied in relation to tumor dissemination and poor prognosis in a limited number of cancers. No such studies have been done on CCR7 expression in non-Hodgkin's lymphoma (T-NHL). Our aim in this paper is to investigate the association between CCR7 expression and progression and prognosis of T-NHL.

Methods

1) Analysis of clinical data: The specimens were obtained from 41 patients with T-NHL and 19 patients with lymphoid hyperplasia. Their corresponding clinicopathologic data were also collected. The expression levels of CCR7, MMP-2, and MMP-9 were examined by immunohistochemical staining. 2) Human T-NHL cell lines Hut 78 (cutaneous T-cell lymphoma) and Jurkat (adult T-cell leukemia/lymphoma) were cultured. The invasiveness of the two cell lines were measured with a Transwell invasion assay, and then used to study the effects of chemokine receptors on T-NHL invasion and the underlying molecular mechanism. The transcript and expression of CCR7 were evaluated using RT-PCR and western blotting.

Results

1) The higher CCR7 and MMP-9 expression ratios were significantly associated with multiple lesions and higher stage III/IV. Moreover, a positive correlation was observed between CCR7 and MMP-9 expression. 2) The Hut 78 cell line was more invasive than the Jurkat cells in the Transwell invasion assay. The transcript and expression levels of CCR7 were significantly higher in Hut78 than that of Jurkat cell line. The T-NHL cell lines were co-cultured with chemokine CCL21 which increased the invasiveness of T-NHL cell. The positive association between CCL21 concentration and invasiveness was found. 3) The stronger transcript and expression of PI3K, Akt and p- Akt were also observed in Hut78 than in Jurkat cell line.

Conclusions

High CCR7 expression in T-NHL cells is significantly associated with lymphatic and distant dissemination as well as with tumor cell migration and invasion in vitro. Its underlying mechanism probably involves the PI3K/Akt signal pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arya M, Patel HR, Williamson M: Chemokines: key players in cancer. Curr Med Res Opin. 2003, 19: 557-64.CrossRefPubMed Arya M, Patel HR, Williamson M: Chemokines: key players in cancer. Curr Med Res Opin. 2003, 19: 557-64.CrossRefPubMed
2.
go back to reference Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O: Secondary lymphoid tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. Biol Chem. 1998, 273 (12): 7118-7122. 10.1074/jbc.273.12.7118.CrossRef Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O: Secondary lymphoid tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. Biol Chem. 1998, 273 (12): 7118-7122. 10.1074/jbc.273.12.7118.CrossRef
3.
go back to reference Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Exp Med. 1998, 188: 373-86. 10.1084/jem.188.2.373.CrossRef Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Exp Med. 1998, 188: 373-86. 10.1084/jem.188.2.373.CrossRef
4.
go back to reference Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells:critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 2000, 60: 2209-17.PubMed Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells:critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 2000, 60: 2209-17.PubMed
5.
go back to reference Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H, Imamura M: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003, 9: 3406-12.PubMed Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H, Imamura M: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003, 9: 3406-12.PubMed
6.
go back to reference Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS: CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res. 2004, 10 (7): 2351-2358.CrossRefPubMed Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS: CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res. 2004, 10 (7): 2351-2358.CrossRefPubMed
7.
go back to reference Saeki H, Moore AM, Brown MJ, Hwang ST: Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol. 1999, 162: 2472-75.PubMed Saeki H, Moore AM, Brown MJ, Hwang ST: Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol. 1999, 162: 2472-75.PubMed
8.
go back to reference Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N, Imamura M: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther. 2004, 3: 29-37.PubMed Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N, Imamura M: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther. 2004, 3: 29-37.PubMed
9.
go back to reference Twitchell DD, London NR, Tomer DP, Tomer S, Murray BK, O'Neill KL: Tannic acid prevents angiogenesis in vivo by inhibiting CXCR4/SDF-1 a binding in breast cancer cells. Proc AACR. 2004, 45: abstract 51- Twitchell DD, London NR, Tomer DP, Tomer S, Murray BK, O'Neill KL: Tannic acid prevents angiogenesis in vivo by inhibiting CXCR4/SDF-1 a binding in breast cancer cells. Proc AACR. 2004, 45: abstract 51-
10.
go back to reference Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-6.CrossRefPubMed Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-6.CrossRefPubMed
11.
go back to reference Takanami I: Over expression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer. 2003, 105 (2): 186-189.CrossRefPubMed Takanami I: Over expression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer. 2003, 105 (2): 186-189.CrossRefPubMed
12.
go back to reference Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M: Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002, 62: 2937-41.PubMed Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M: Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002, 62: 2937-41.PubMed
13.
go back to reference Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST: Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst. 2001, 93: 1638-43.CrossRefPubMed Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST: Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst. 2001, 93: 1638-43.CrossRefPubMed
14.
go back to reference Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, Nakano H, Hohenberger W, Lipp M, Förster R: CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med. 2001, 194: 1875-81.PubMedCentralCrossRefPubMed Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, Nakano H, Hohenberger W, Lipp M, Förster R: CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med. 2001, 194: 1875-81.PubMedCentralCrossRefPubMed
15.
go back to reference Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, Cyster JG: Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med. 2002, 196: 65-75.PubMedCentralCrossRefPubMed Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, Cyster JG: Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med. 2002, 196: 65-75.PubMedCentralCrossRefPubMed
16.
go back to reference Stein JV, Soriano SF, M'rini C, Nombela-Arrieta C, de Buitrago GG, Rodríguez-Frade JM, Mellado M, Girard JP, Martínez-AC C: CR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood. 2003, 101: 38-44.CrossRefPubMed Stein JV, Soriano SF, M'rini C, Nombela-Arrieta C, de Buitrago GG, Rodríguez-Frade JM, Mellado M, Girard JP, Martínez-AC C: CR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood. 2003, 101: 38-44.CrossRefPubMed
17.
go back to reference Ma F, Zhang SR, Ning L, Sun WX, Liang X, Zhang XY, Fu M, Lin C: Construction of eukaryotic expression vector of murine SLC gene and characterization of its chemotactic function. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003, 19 (6): 528-30.PubMed Ma F, Zhang SR, Ning L, Sun WX, Liang X, Zhang XY, Fu M, Lin C: Construction of eukaryotic expression vector of murine SLC gene and characterization of its chemotactic function. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003, 19 (6): 528-30.PubMed
18.
go back to reference Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, Lipp M, Ibrahim S, Efstratiadis A, Zagzag D, Bromberg JS, Dustin ML, Aifantis I: CCR7 signaling as an essential regulator of CNS infiltration in T-cell leukemia. Nature. 2009, 459 (7249): 1000-4.PubMedCentralCrossRefPubMed Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, Lipp M, Ibrahim S, Efstratiadis A, Zagzag D, Bromberg JS, Dustin ML, Aifantis I: CCR7 signaling as an essential regulator of CNS infiltration in T-cell leukemia. Nature. 2009, 459 (7249): 1000-4.PubMedCentralCrossRefPubMed
19.
go back to reference Stetler-Stevenson WG, Kleiner DE: Molecular biology of cancer: invasion and metastases. Philadelphia: Lippincott & Wilkins, 2001, 123-36. Stetler-Stevenson WG, Kleiner DE: Molecular biology of cancer: invasion and metastases. Philadelphia: Lippincott & Wilkins, 2001, 123-36.
20.
go back to reference Nomura T, Hasegawa H: Chemokines and anti-cancer immunotherapy: Anti-tumor effect of EBL1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC). Anticancer Res. 2000, 20 (6A): 4073-4080.PubMed Nomura T, Hasegawa H: Chemokines and anti-cancer immunotherapy: Anti-tumor effect of EBL1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC). Anticancer Res. 2000, 20 (6A): 4073-4080.PubMed
21.
go back to reference Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD: Cellular function of phosphoinositide-3-kinases: imp lications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001, 17: 615-675.CrossRefPubMed Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD: Cellular function of phosphoinositide-3-kinases: imp lications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001, 17: 615-675.CrossRefPubMed
22.
go back to reference Xu X, Sakon M, Nagano H, Hiraoka N, Yamamoto H, Hayashi N, Dono K, Nakamori S, Umeshita K, Ito Y, Matsuura N, Monden M: Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep. 2005, 11: 25-32. Xu X, Sakon M, Nagano H, Hiraoka N, Yamamoto H, Hayashi N, Dono K, Nakamori S, Umeshita K, Ito Y, Matsuura N, Monden M: Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep. 2005, 11: 25-32.
23.
go back to reference Yamamoto S, Tomita Y, Hoshida Y, Morooka T, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden M, Aozasa K: Prognostic significance of activated akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004, 10: 2846-2850.CrossRefPubMed Yamamoto S, Tomita Y, Hoshida Y, Morooka T, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden M, Aozasa K: Prognostic significance of activated akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004, 10: 2846-2850.CrossRefPubMed
24.
go back to reference Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005, 94: 29-86.CrossRefPubMed Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005, 94: 29-86.CrossRefPubMed
25.
go back to reference Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005, 24: 7455-7464.CrossRefPubMed Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005, 24: 7455-7464.CrossRefPubMed
26.
go back to reference Nicholson KM, Anderson NG: The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal. 2002, 14: 381-395.CrossRefPubMed Nicholson KM, Anderson NG: The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal. 2002, 14: 381-395.CrossRefPubMed
27.
go back to reference Sánchez-Sánchez N, Riol-Blanco L, de la Rosa G, Puig-Kröger A, García-Bordas J, Martín D, Longo N, Cuadrado A, Cabañas C, Corbí AL, Sánchez-Mateos P, Rodríguez-Fernández JL: Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood. 2004, 104 (3): 619-CrossRefPubMed Sánchez-Sánchez N, Riol-Blanco L, de la Rosa G, Puig-Kröger A, García-Bordas J, Martín D, Longo N, Cuadrado A, Cabañas C, Corbí AL, Sánchez-Mateos P, Rodríguez-Fernández JL: Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood. 2004, 104 (3): 619-CrossRefPubMed
28.
go back to reference Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Annual. 2002, 52 (4): 255-264. Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Annual. 2002, 52 (4): 255-264.
29.
go back to reference Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A, Nakata K, Kogawa K, Koito K, Hareyama M, Himi T: Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgekin's lymphoma. Cancer. 2004, 100: 356-365.CrossRefPubMed Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A, Nakata K, Kogawa K, Koito K, Hareyama M, Himi T: Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgekin's lymphoma. Cancer. 2004, 100: 356-365.CrossRefPubMed
30.
go back to reference Arlt M, Kopitz C, Pennington C, Watson KL, Krell HW, Bode W, Gansbacher B, Khokha R, Edwards DR, Krüger A: Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res. 2002, 62 (19): 5543-5550.PubMed Arlt M, Kopitz C, Pennington C, Watson KL, Krell HW, Bode W, Gansbacher B, Khokha R, Edwards DR, Krüger A: Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res. 2002, 62 (19): 5543-5550.PubMed
Metadata
Title
Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study
Authors
Jing Yang
Shengyi Wang
Guofan Zhao
Baocun Sun
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2011
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-30-51

Other articles of this Issue 1/2011

Journal of Experimental & Clinical Cancer Research 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine